World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
43797
World Ranking
9911
National Ranking
350

Overview

Paolo Bruzzi is affiliated with Ospedale San Martino in Italy and specializes in the field of medicine, with a particular focus on oncology. Their research spans several subfields including oncology, pulmonary and respiratory medicine, cancer research, surgery, and neurology.

The scientist has contributed extensively to studies related to breast cancer treatment, cancer genomics and diagnostics, COVID-19 clinical research, sarcoma diagnosis and treatment, advanced breast cancer therapies, colorectal cancer treatments, and cancer pharmacology.

Paolo Bruzzi's notable recent publications highlight a range of clinical and therapeutic studies in these areas:

  • Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia, 2020, JAMA Internal Medicine
  • Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups, 2020, Journal of Clinical Oncology
  • Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial, 2022, Annals of Surgical Oncology
  • Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial, 2021, Cancer
  • Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial, 2021, The Lancet Oncology

Frequent coauthors collaborating with Paolo Bruzzi include:

  • Luca Boni
  • E. Barbieri
  • Giuseppe Canavese
  • Corrado Tinterri
  • Damiano Gentile

They publish regularly in several key venues, with most contributions appearing in:

  • Journal of Clinical Oncology
  • European Journal of Surgical Oncology
  • Annals of Oncology
  • Zenodo (CERN European Organization for Nuclear Research)
  • Annals of Surgical Oncology

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • ESTIMATING THE POPULATION ATTRIBUTABLE RISK FOR MULTIPLE RISK FACTORS USING CASE-CONTROL DATA

    Paolo Bruzzi;Sylvan B. Green;David P. Byar;Louise A. Brinton

  • Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.

    Paolo Spirito;Pietro Bellone;Kevin M. Harris;Paola Bernabò

  • Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy

    Barry J. Maron;Paolo Spirito;Win Kuang Shen;Tammy S. Haas

  • Adjuvant mitotane treatment for adrenocortical carcinoma.

    Massimo Terzolo;Alberto Angeli;Martin Fassnacht;Fulvia Daffara

  • Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.

    Carlo Salvarani;Giovanni Dolci;Marco Massari;Domenico Franco Merlo

  • Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)

    Andrea Bacigalupo;Teresa Lamparelli;Paolo Bruzzi;Stefano Guidi

  • Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Paolo G. Casali;Jean-Yves Blay;Alexia Bertuzzi;Stefan Bielack

  • Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.

    Alessandro Gronchi;Stefano Ferrari;Vittorio Quagliuolo;Javier Martin Broto

  • HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials

    Alessandra Gennari;Maria Pia Sormani;Paolo Pronzato;Matteo Puntoni

  • Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

    Fabio Ciceri;Chiara Bonini;Maria Teresa Lupo Stanghellini;Attilio Bondanza

  • Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.

    Andrea Bacigalupo;Teresa Lamparelli;Giovanni Barisione;Paolo Bruzzi

  • Syncope and risk of sudden death in hypertrophic cardiomyopathy.

    Paolo Spirito;Camillo Autore;Claudio Rapezzi;Paola Bernabò

  • Treatment of Advanced Squamous-Cell Carcinoma of the Head and Neck with Alternating Chemotherapy and Radiotherapy

    Marco Merlano;Vito Vitale;Riccardo Rosso;Marco Benasso

  • Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    Richard Gray;Rosie Bradley;Jeremy Braybrooke;Zulian Liu

  • MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials

    Maria Pia Sormani;Paolo Bruzzi

  • False-Positive Galactomannan Platelia Aspergillus Test Results for Patients Receiving Piperacillin-Tazobactam

    Claudio Viscoli;Marco Machetti;Paola Cappellano;Barbara Bucci

  • Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial

    Bernardo Bonanni;Matteo Puntoni;Massimiliano Cazzaniga;Giancarlo Pruneri

  • The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms

    Camillo Autore;Paola Bernabò;Caterina Stella Barillà;Paolo Bruzzi

  • Actual and preferred place of death of cancer patients. Results from the Italian survey of the dying of cancer (ISDOC)

    Monica Beccaro;Massimo Costantini;Paolo Giorgi Rossi;Guido Miccinesi

Frequent Co-Authors

Maria Pia Sormani
Maria Pia Sormani University of Genoa
Pierfranco Conte
Pierfranco Conte University of Padua
Dino Amadori
Dino Amadori University of Bologna
Claudio Viscoli
Claudio Viscoli University of Genoa
Andrea Ardizzoni
Andrea Ardizzoni University of Bologna
Domenico Palli
Domenico Palli Institute for the Study and Prevention of Cancer (Istituto per lo Studio, la Prevenzione e la Rete Oncologica)
Lisa Licitra
Lisa Licitra University of Milan
Paolo G. Casali
Paolo G. Casali University of Milan
Francesco Cognetti
Francesco Cognetti Sapienza University of Rome
Massimo Filippi
Massimo Filippi Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare careers beyond traditional medical school? There are many accredited online programs offering alternative routes into the medical field. For those drawn to administrative and data-focused roles, medical billing and coding online schools provide convenient and affordable pathways into healthcare administration and insurance processing.

Aspiring nurses who wish to bypass certain entry exams should explore nursing school without teas test requirements. These schools allow students to focus on their coursework and clinical training instead of preparatory exams.

For those aiming for leadership, an accredited healthcare administration degree online accredited can fast-track your entry into management roles within hospitals, clinics, or insurance companies.

Registered nurses looking to advance their qualifications and practice can look into asn to fnp programs. These bridge programs offer a streamlined approach from an Associate Degree in Nursing to becoming a Family Nurse Practitioner, expanding your clinical responsibilities.

Best Scientists Citing Paolo Bruzzi

Trending Scientists

Recently Published Articles